Enhancing photoreceptor integration using microglia-derived secreted factors

使用小胶质细胞衍生的分泌因子增强光感受器整合

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The retina, like many other regions of the nervous system, is subject to a variety of inherited and acquired degenerative conditions. These conditions often result in the degeneration of the photoreceptors, the main light sensing cells in the retina. Despite the loss of photoreceptors, the inner retinal circuitry is intact for many year, and this has led to the possibility of photoreceptor replacement as a potential therapy. Cell replacement strategy is important as the loss of photoreceptors in the mammalian retina is not associated with any effective regeneration from resident cells. A potential source of cellular replacement could be pluripotent stem cells. There are a number of groups looking into the potential of stem cell derived RPE including an approved clinical trial for RPE cell replacement for AMD and Stargardt dystrophy. However, as the disease progresses to vision loss, patients will require replacement of the lost photoreceptor cells as well. Although a number of groups have shown integration of photoreceptors in the mouse retina, the overall efficiency is really low. Additionally, the role of the microglia in this process has largely been unexplored. This proposal aims to look at the role of microglia-derived neurotrophic factors in both retinal repair and regenerative medicine. We will use a cross-species approach to identify and carry out basic studies in flies and apply the result in mammalian retinas.
 描述(由申请人提供):视网膜,像许多其他区域的神经系统,是受各种遗传和后天变性条件。这些条件通常导致光感受器的变性,光感受器是视网膜中的主要感光细胞。尽管失去了光感受器,但内部视网膜回路多年来都是完整的,这导致了光感受器替代作为潜在治疗的可能性。细胞替换策略是重要的,因为哺乳动物视网膜中光感受器的损失与从驻留细胞的任何有效再生无关。细胞替代的一个潜在来源可能是多能干细胞。有许多小组正在研究干细胞衍生的RPE的潜力,包括一项已批准的用于AMD和Stargardt营养不良的RPE细胞替代的临床试验。然而,随着疾病进展到视力丧失,患者也需要更换丢失的感光细胞。尽管许多研究小组已经证明了小鼠视网膜中的光感受器的整合,但整体效率确实很低。 此外,小胶质细胞在这一过程中的作用在很大程度上尚未探索。该提案旨在研究小胶质细胞源性神经营养因子在视网膜修复和再生医学中的作用。我们将使用跨物种的方法来识别和进行果蝇的基础研究,并将结果应用于哺乳动物视网膜。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small Molecule-Based Retinal Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.
基于小分子的人胚胎干细胞和诱导多能干细胞的视网膜分化。
  • DOI:
    10.21769/bioprotoc.2882
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0.8
  • 作者:
    Zhu,Jie;Lamba,DeepakA
  • 通讯作者:
    Lamba,DeepakA
Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line.
从当前良好生产规范制造的人类诱导多能干细胞系中产生可移植的视网膜感光器。
  • DOI:
    10.1002/sctm.17-0205
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Zhu,Jie;Reynolds,Joseph;Garcia,Thelma;Cifuentes,Helen;Chew,Shereen;Zeng,Xianmin;Lamba,DeepakAshok
  • 通讯作者:
    Lamba,DeepakAshok
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deepak Ashok Lamba其他文献

Deepak Ashok Lamba的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deepak Ashok Lamba', 18)}}的其他基金

Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
  • 批准号:
    10319983
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Lamba Admin Supp cryo-storage
Lamba Admin Supp 低温存储
  • 批准号:
    10833913
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Lamba_Admin_Supp_Re_Entry_Mar2022
Lamba_Admin_Supp_Re_Entry_Mar2022
  • 批准号:
    10596052
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
  • 批准号:
    10370911
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
  • 批准号:
    10531241
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
  • 批准号:
    10514970
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
iPSC 衍生的显性 LCA 模型的机制分析和等位基因组编辑
  • 批准号:
    10723137
  • 财政年份:
    2021
  • 资助金额:
    $ 40.31万
  • 项目类别:
Enhancing photoreceptor integration using microglia-derived secreted factors
使用小胶质细胞衍生的分泌因子增强光感受器整合
  • 批准号:
    9250155
  • 财政年份:
    2016
  • 资助金额:
    $ 40.31万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 40.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了